Approval · Notice of Compliance 22472 · 2019
ATAJECT: Notice of Compliance 22472
Issued July 29, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22472
- Date
- July 29, 2019
- Company
- Grey Wolf Animal Health IncToronto, Ontario, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- ANTISEDAN (Orion Corporation)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATAJECT | 02490900 | Marketed |
Medicinal ingredients
- ATIPAMEZOLE HYDROCHLORIDE 5 MG per ML